SCHEDULE 13D/A

Armata Pharmaceuticals, Inc.

Common Stock, $0.01 par value · CUSIP: 04216R102

Event date: 2025-03-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Innoviva, Inc.Reported CIK 0001080014

  Shares: 64,178,259 · Class: 85.2%

• Innoviva Strategic Opportunities LLC

  Shares: 46,756,659 · Class: 62.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.